Michael Amoroso sold $172k of DTIL
President and CEO at PRECISION BIOSCIENCES INC. 36,838 shares at an average of $4.67, traded Jan 21, 2025, filed Jan 22, 2025.
Score components
- +25RoleCEO
- +11Trade size$172k at market
- +10Share of holdings soldSold 26% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-008013, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 20, 2025 | MOption exercise Common Stock10b5-1 | +115,388 | - | - | 143,925 | Jan 22, 2025 |
| Jan 21, 2025 | SOpen-market sale Common Stock10b5-1 | -36,838 | $4.67 | $172k | 107,087 | Jan 22, 2025 |
| Jan 20, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -8,888 | $0.00 | $0 | 8,888 | Jan 22, 2025 |
| Jan 20, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -37,079 | $0.00 | $0 | 74,138 | Jan 22, 2025 |
| Jan 20, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -69,421 | $0.00 | $0 | 138,842 | Jan 22, 2025 |
Related signals
Other insiders at PRECISION BIOSCIENCES INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | PRECISION BIOSCIENCES INC | Stanley Frankel director | $6,000 1,000 shares | +2% | |
| 38Weak | PRECISION BIOSCIENCES INC | Melinda Brown director | $7,116 1,135 shares | +3% | |
| 41Moderate | PRECISION BIOSCIENCES INC | Geno J Germano director | $16k 2,609 shares | +6% | |
| 34Weak | PRECISION BIOSCIENCES INC | Melinda Brown director | $6,963 1,682 shares | +9% | |
| 37Weak | PRECISION BIOSCIENCES INC | Kevin Buehler director | $21k 5,076 shares | +22% | |
| 49Moderate | PRECISION BIOSCIENCES INC | Melinda Brown director | $8,735 1,839 shares | +25% | |
| 53Moderate | PRECISION BIOSCIENCES INC | Kevin Buehler director | $21k 4,523 shares | +52% | |
| 49Moderate | PRECISION BIOSCIENCES INC | Geno J Germano director | $17k 3,250 shares | +42% | |
| 0Weak | PRECISION BIOSCIENCES INC | Michael Amoroso President and CEO | $5,360 964 shares | -1% | |
| 58Moderate | PRECISION BIOSCIENCES INC | Geno J Germano director | $16k 3,605 shares | +86% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.